Publications

Nature biotechnology

T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes.

01-04-2022

Oncoimmunology

QPCTL regulates macrophage and monocyte abundance and inflammatory signatures in the tumor microenvironment.

22-03-2022

Current opinion in immunology

Safety switches for adoptive cell therapy.

01-02-2022

Science (New York, N.Y.)

Tertiary lymphoid structures in cancer.

07-01-2022

Nature communications

Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma.

22-12-2021

Science (New York, N.Y.)

An atlas of intratumoral T cells.

17-12-2021

Cell reports

Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8⁺ T cells.

16-11-2021

Nature chemical biology

Single-cell analysis of regions of interest (SCARI) using a photosensitive tag.

01-11-2021

Proceedings of the National Academy of Sciences of the United States of America

Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response.

26-10-2021

Human gene therapy

Multimodular Optimization of Chemically Regulated T Cell Switches Demonstrates Flexible and Interchangeable Nature of Immune Cell Signaling Domains.

01-10-2021

Cancer discovery

Anti-Inflammatory Drugs Remodel the Tumor Immune Environment to Enhance Immune Checkpoint Blockade Efficacy.

01-10-2021

Cancer immunology research

CRASH-IT Switch Enables Reversible and Dose-Dependent Control of TCR and CAR T-cell Function.

01-09-2021

Cold Spring Harbor perspectives in biology

Formation of Tissue-Resident CD8⁺ T-Cell Memory.

02-08-2021

Journal for immunotherapy of cancer

HPV-16 E6/E7 DNA tattoo vaccination using genetically optimized vaccines elicit clinical and immunological responses in patients with usual vulvar intraepithelial neoplasia (uVIN): a phase I/II clinical trial.

01-08-2021

Nature medicine

An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer.

01-07-2021

Nature communications

Identification and characterization of a SARS-CoV-2 specific CD8⁺ T cell response with immunodominant features.

10-05-2021

Current opinion in immunology

Modulation of the tumor micro-environment by CD8⁺ T cell-derived cytokines.

01-04-2021

Nature protocols

Labeling and tracking of immune cells in ex vivo human skin.

01-02-2021

Nature medicine

Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma.

01-02-2021

Nature medicine

Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial.

01-12-2020

Key Publication

Journal for immunotherapy of cancer

Comprehensive analysis of cutaneous and uveal melanoma liver metastases.

01-12-2020

Cell

Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction.

29-10-2020

The Journal of experimental medicine

A committed tissue-resident memory T cell precursor within the circulating CD8+ effector T cell pool.

05-10-2020

Journal for immunotherapy of cancer

Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up.

01-08-2020

Nature cancer

Publisher Correction: Long-distance modulation of bystander tumor cells by CD8⁺ T-cell-secreted IFN-γ.

01-07-2020

Nature immunology

Author Correction: Tissue patrol by resident memory CD8⁺ T cells in human skin.

01-06-2020

Communications biology

A mouse model that is immunologically tolerant to reporter and modifier proteins.

29-05-2020

Immunity

The CD47-SIRPα Immune Checkpoint.

19-05-2020

Cancer immunology research

Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells.

01-05-2020

Nature medicine

Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers.

01-04-2020

Nature reviews. Cancer

CD8⁺ T cell states in human cancer: insights from single-cell analysis.

01-04-2020

Proceedings of the National Academy of Sciences of the United States of America

CD29 identifies IFN-γ-producing human CD8⁺ T cells with an increased cytotoxic potential.

24-03-2020

Nature cancer

Long-distance modulation of bystander tumor cells by CD8⁺ T cell-secreted IFNγ.

01-03-2020

Immunity

Quorum Regulation via Nested Antagonistic Feedback Circuits Mediated by the Receptors CD28 and CTLA-4 Confers Robustness to T Cell Population Dynamics.

18-02-2020

Nature protocols

Tumor organoid-T-cell coculture systems.

01-01-2020

Nature

B cells and tertiary lymphoid structures promote immunotherapy response.

01-01-2020

Nature communications

Author Correction: Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection.

26-11-2019

Nature reviews. Immunology

Defining 'T cell exhaustion'.

01-11-2019

Nature communications

Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection.

01-11-2019

Nature

Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis.

01-08-2019

Key Publication

Cell

Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold.

25-07-2019

The Lancet. Oncology

Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial.

01-07-2019

Nature medicine

Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial.

01-07-2019

Nature immunology

Tissue patrol by resident memory CD8⁺ T cells in human skin.

01-06-2019

Nature protocols

Induction of neoantigen-reactive T cells from healthy donors.

01-06-2019

Nature medicine

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial.

01-06-2019

Annual review of immunology

Cancer Neoantigens.

26-04-2019

Nature communications

Publisher Correction: Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer.

24-04-2019

Cancer immunology research

Radiotherapy and Cisplatin Increase Immunotherapy Efficacy by Enabling Local and Systemic Intratumoral T-cell Activity.

01-04-2019

Cancer immunology research

Broad Cytotoxic Targeting of Acute Myeloid Leukemia by Polyclonal Delta One T Cells.

01-04-2019

T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes.

QPCTL regulates macrophage and monocyte abundance and inflammatory signatures in the tumor microenvironment.

Safety switches for adoptive cell therapy.

Tertiary lymphoid structures in cancer.

Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma.

An atlas of intratumoral T cells.

Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8+ T cells.

Single-cell analysis of regions of interest (SCARI) using a photosensitive tag.

Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response.

Multimodular Optimization of Chemically Regulated T Cell Switches Demonstrates Flexible and Interchangeable Nature of Immune Cell Signaling Domains.

Anti-Inflammatory Drugs Remodel the Tumor Immune Environment to Enhance Immune Checkpoint Blockade Efficacy.

CRASH-IT Switch Enables Reversible and Dose-Dependent Control of TCR and CAR T-cell Function.

Formation of Tissue-Resident CD8+ T-Cell Memory.

HPV-16 E6/E7 DNA tattoo vaccination using genetically optimized vaccines elicit clinical and immunological responses in patients with usual vulvar intraepithelial neoplasia (uVIN): a phase I/II clinical trial.

An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer.

Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features.

Modulation of the tumor micro-environment by CD8+ T cell-derived cytokines.

Labeling and tracking of immune cells in ex vivo human skin.

Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma.

Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial.

Comprehensive analysis of cutaneous and uveal melanoma liver metastases.

Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction.

A committed tissue-resident memory T cell precursor within the circulating CD8+ effector T cell pool.

Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up.

Publisher Correction: Long-distance modulation of bystander tumor cells by CD8+ T-cell-secreted IFN-γ.

Author Correction: Tissue patrol by resident memory CD8+ T cells in human skin.

A mouse model that is immunologically tolerant to reporter and modifier proteins.

The CD47-SIRPα Immune Checkpoint.

Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells.

Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers.

CD8+ T cell states in human cancer: insights from single-cell analysis.

CD29 identifies IFN-γ-producing human CD8+ T cells with an increased cytotoxic potential.

Long-distance modulation of bystander tumor cells by CD8+ T cell-secreted IFNγ.

Quorum Regulation via Nested Antagonistic Feedback Circuits Mediated by the Receptors CD28 and CTLA-4 Confers Robustness to T Cell Population Dynamics.

Tumor organoid-T-cell coculture systems.

B cells and tertiary lymphoid structures promote immunotherapy response.

Author Correction: Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection.

Defining 'T cell exhaustion'.

Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection.

Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis.

Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold.

Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial.

Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial.

Tissue patrol by resident memory CD8+ T cells in human skin.

Induction of neoantigen-reactive T cells from healthy donors.

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial.

Cancer Neoantigens.

Publisher Correction: Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer.

Radiotherapy and Cisplatin Increase Immunotherapy Efficacy by Enabling Local and Systemic Intratumoral T-cell Activity.

Broad Cytotoxic Targeting of Acute Myeloid Leukemia by Polyclonal Delta One T Cells.

This site uses cookies

Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8⁺ T cells.

Formation of Tissue-Resident CD8⁺ T-Cell Memory.

Identification and characterization of a SARS-CoV-2 specific CD8⁺ T cell response with immunodominant features.

Modulation of the tumor micro-environment by CD8⁺ T cell-derived cytokines.

Publisher Correction: Long-distance modulation of bystander tumor cells by CD8⁺ T-cell-secreted IFN-γ.

Author Correction: Tissue patrol by resident memory CD8⁺ T cells in human skin.

CD8⁺ T cell states in human cancer: insights from single-cell analysis.

CD29 identifies IFN-γ-producing human CD8⁺ T cells with an increased cytotoxic potential.

Long-distance modulation of bystander tumor cells by CD8⁺ T cell-secreted IFNγ.

Tissue patrol by resident memory CD8⁺ T cells in human skin.